Literature DB >> 2495346

CD4 percentage, CD4 number, and CD4:CD8 ratio in HIV infection: which to choose and how to use.

J M Taylor1, J L Fahey, R Detels, J V Giorgi.   

Abstract

Data from a 3 year longitudinal study of CD4 levels in 813 untreated HIV-seropositive men are presented. Baseline CD4 levels were used to stratify the men for the severity of HIV disease at the outset of the study, and each man's CD4 levels and progression to AIDS were evaluated. These data can be used to advise patients who are HIV seropositive on the likelihood that they will deteriorate immunologically or progress to AIDS based on their own CD4 cell level obtained from laboratory evaluation. Graphs are presented here for 1, 2, and 3 years of follow-up. As expected, each individual's absolute CD4 lymphocyte number, CD4 lymphocyte percent, and CD4:CD8 ratio were strongly correlated, and were similar in their ability to predict the development of AIDS. In this sense, all three are useful markers for monitoring individuals with HIV infection, and for many clinical situations from a practical point of view there is little to choose between the markers. However, the CD4 percent has slightly greater prognostic significance and shows slightly less variability on repeated measurements. Because of this, the CD4 percent may be preferable to the CD4 absolute number for use in stratifying individuals who are candidates for antiviral or immunotherapy for HIV infection, and for monitoring patients in clinical trials.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2495346

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr (1988)        ISSN: 0894-9255


  63 in total

1.  Quantitative trait loci on chromosomes 1, 2, 3, 4, 8, 9, 11, 12, and 18 control variation in levels of T and B lymphocyte subpopulations.

Authors:  M A Hall; P J Norman; B Thiel; H Tiwari; A Peiffer; R W Vaughan; S Prescott; M Leppert; N J Schork; J S Lanchbury
Journal:  Am J Hum Genet       Date:  2002-04-09       Impact factor: 11.025

2.  Reference ranges and sources of variability of CD4 counts in HIV-seronegative women and men.

Authors:  M K Maini; R J Gilson; N Chavda; S Gill; A Fakoya; E J Ross; A N Phillips; I V Weller
Journal:  Genitourin Med       Date:  1996-02

3.  Effects of two cognitive-behavioral interventions on immunity and symptoms in persons with HIV.

Authors:  R N Lucille Sanzero Eller
Journal:  Ann Behav Med       Date:  1995-12

Review 4.  Monitoring of lymphocyte subpopulation changes in the assessment of HIV infection.

Authors:  A G Bird
Journal:  Genitourin Med       Date:  1990-06

5.  The Italian quality control study for evaluation of CD4 cells in centres involved in the treatment of HIV-1 patients. Italian CD4 Quality Control Group.

Authors:  F Pandolfi; C Alario; E Girardi; L Rava; G Ippolito; A Kunkl; F Aiuti
Journal:  Clin Exp Immunol       Date:  1998-03       Impact factor: 4.330

6.  Orocutaneous Manifestations as Markers of Disease Progression in HIV Infection in Indian Setting.

Authors:  Y K Sharma; Mps Sawhney; D S Bhakuni; V Gera
Journal:  Med J Armed Forces India       Date:  2011-07-21

7.  Asymptomatic CMV Replication During Early Human Immunodeficiency Virus (HIV) Infection Is Associated With Lower CD4/CD8 Ratio During HIV Treatment.

Authors:  Davey M Smith; Masato Nakazawa; Michael L Freeman; Christy M Anderson; Michelli F Oliveira; Susan J Little; Sara Gianella
Journal:  Clin Infect Dis       Date:  2016-09-06       Impact factor: 9.079

8.  CD4/CD8 ratio is a promising candidate for non-invasive measurement of liver fibrosis in chronic HCV-monoinfected patients.

Authors:  Thijs Feuth; Debbie van Baarle; Karel J van Erpecum; Peter D Siersema; Andy I M Hoepelman; Joop E Arends
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-01-22       Impact factor: 3.267

Review 9.  Human Immunodeficiency Virus Infection and Host Defense in the Lungs.

Authors:  Tysheena P Charles; Judd E Shellito
Journal:  Semin Respir Crit Care Med       Date:  2016-03-14       Impact factor: 3.119

10.  Hematological reference ranges among healthy Ugandans.

Authors:  S B Tugume; E M Piwowar; T Lutalo; P N Mugyenyi; R M Grant; F W Mangeni; K Pattishall; E Katongole-Mbidde
Journal:  Clin Diagn Lab Immunol       Date:  1995-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.